Borrelia burgdorferi IgG antibody by Immunofluorescence Assay (serum/plasma)
This test detects antibodies in your blood that your immune system produces in response to *Borrelia burgdorferi*, the bacterium responsible for Lyme disease. It helps diagnose infections caused by tick bites.
["This test checks for past or current Lyme disease exposure by measuring specific antibodies in your blood."]
Key facts at a glance
- LOINC
- 9708-9
- Short code
- COXPH1
- Synonyms
- C burnet Ph1 IgG Titr Ser
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST), red-top tube, or gold-top tube
- Units
- N/A
- Ref low
- 0
- Ref high
- 1
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Immunofluorescence Assay (IFA)
- CPT
- 86638
- SNOMED
- 302002005
- Specimen volume
- 1-2 mL serum (minimum 0.5 mL)
- Stability
- Room temperature: 8 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or lower): 30 days. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 100
- Lipemia max
- 50
- Icterus max
- 20
- TAT
- 48–168 hours
- Order
- routine
What This Test Measures
The test uses immunofluorescence to identify IgG antibodies against *Borrelia burgdorferi* antigens. These antibodies develop after your body encounters the bacterium, often weeks to months after infection. The method detects these antibodies by binding them to labeled markers under a microscope.
How the Test Works
Your blood sample is processed to separate serum or plasma, where the test looks for IgG antibodies. If antibodies are present, they bind to specific *Borrelia* antigens on a microscopic slide, creating visible markers that indicate a positive result.
Why It Matters
IgG antibodies remain in your system for months or years after infection, making this test useful for diagnosing Lyme disease in early or late stages. It can also help confirm a diagnosis if symptoms are unclear or if other tests are inconclusive.
When You Might Need This Test
Your healthcare provider may recommend this test if you’ve had a tick bite, have symptoms like fever, rash, joint pain, or neurological issues, or if you live in an area with high Lyme disease risk. It’s often used alongside other tests, such as culture or PCR, for confirmation.
Reference range
Negative: <1:200; Equivocal: 1:200; Positive: ≥1:200 (titer endpoint reported as reciprocal of highest dilution with positive reactivity)N/A
No fasting required. No special patient preparation needed. Acute and convalescent serum samples (2-4 weeks apart) are recommended for seroconversion assessment.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Positive results suggest past or current *Borrelia burgdorferi* infection, but false positives can occur due to cross-reactions with other bacteria or prior vaccinations. Negative results don’t always rule out Lyme disease, especially if testing is done too early. Results should be interpreted alongside clinical findings and other diagnostic tests.
Short name
IgG Antibody to Lyme Disease Spirochete
Frequently asked questions
How soon after infection might I get a positive result?
Can I get this test at home?
Does this test show active Lyme disease?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy